Ding et al. [83] reported the association of GSTT1 and/or GSTM1-null genotypes with an increased risk of developing pulmonary fibrosis in patients with chronic obstructive pulmonary disease (COPD), one of the more important COVID-19 complications characterizing long-term respiratory problems. Here, GSTM1 is linked to chronic obstructive pulmonary disease.